Table 3.

Asthmatic patients according to inflammatory phenotypes (T2/ non-T2).

General characteristics	T2 phenotype	Non-T2 phenotype	P
Gender: female (%)	78.77	82.76	NS
Current age (years, mean ± SD)	51.53 (17.41)	60.24 (14.96)	<0.01*
Age at onset of symptoms (years, mean ± SD)	16.50 (14.98)	33.33 (20.75)	<0.0001*
Duration of disease (years, mean ± SD)	35.06 (15.85)	27.04 (19.14)	<0.01*
Severe asthma (steps 4 and 5 of GINA) (%)	77.65	41.83	<0.001#
COVID-19 (%)	27.37	34.48	NS
Obesity (%)	39.66	37.92	NS
Hypertension (%)	34.64	58.62	NS
Dyslipidemia (%)	16.76	20.69	NS
Diabetes mellitus (%)	15.08	24.14	NS
Total serum IgE (UI/mL) (median, range)	280.30 (10.8–8,310)	94.80 (8.2–1,722)	<0.0001#
Peripheral eosinophils (cells/μL) (median ± SD)	261.47 (231.26)	192.41 (150.54)	0.099#

SD, standard deviation; GINA, Global Initiative for Asthma.

^*Mann-Whitney test.

^#Chi-square test.